CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities:
Consolidated net income	$ 34.3	$ 38.9
Adjustments to reconcile consolidated net income to cash flows from operating activities:
Depreciation and amortization	25.7	14.7
Amortization of deferred financing costs	0.3	0.3
Write down of inventories to net realizable value	19.4	11.2
Stock-based compensation	3.8	3.3
Deferred income taxes	(4.3)	(8.2)
Loss on divestiture of business		1.0
Other non-cash expense	0.7	1.9
Changes in operating assets and liabilities:
Accounts receivable	(28.4)	9.4
Inventories	(82.0)	(48.8)
Accounts payable	13.0	9.3
Customer deposits	2.9	13.8
Other changes in operating assets and liabilities, net	(11.0)	6.3
Net cash (used) in provided by operating activities	(25.6)	53.1
Cash flows from investing activities:
Acquisitions, net of cash acquired	(1.3)	(37.8)
Purchases of property, plant and equipment	(31.2)	(10.7)
Net cash used in investing activities	(32.5)	(48.5)
Cash flows from financing activities:
Repayments of revolving lines of credit, net	(0.3)	(0.4)
Repayment of term debt	(13.7)	(9.9)
Payment of deferred financing costs	(1.2)
Proceeds from issuance of common stock, net	3.0	2.2
Changes in restricted cash	(1.4)	(0.7)
Cash payments to noncontrolling interest	(0.4)	(0.1)
Net cash used in financing activities	(14.0)	(8.9)
Effect of exchange rate changes on cash and cash equivalents	11.5	(15.2)
Net change in cash and cash equivalents	(60.6)	(19.5)
Cash and cash equivalents at beginning of period	230.4	207.1
Cash and cash equivalents at end of period	169.8	187.6
Non-cash financing activities:
Issuance of common stock in connection with acquisition of Michrom Bioresources Inc.	$ 2.9